ニュース

Ozempic approved in Canada to slow kidney decline, prevent cardiovascular disease

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
The Canadian Press on MSN1 日

Health Canada approves Ozempic to reduce kidney decline in people with Type 2 diabetes

An international clinical trail showed the risk of kidneys deteriorating or failing was lower in patients taking Ozempic, as ...

Canadians could get more affordable version of Ozempic in early 2026. Here's how

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

Canada approves Ozempic to reduce risk of diabetic kidney disease progression

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, to reduce the risk of kidney failure and ...

Health Matters: Health Canada approves Ozempic to help reduce kidney decline

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...
Stocktwits on MSN1 日

Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline ...

Danish drugmaker Novo Nordisk (NVO) on Tuesday said that its blockbuster drug Ozempic is now approved in Canada to reduce the ...
Cantech Letter1 日

Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage ...

Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...